FOXO4 (10mg)

Mechanism of Action: How FOXO4 (10mg) Works

FOXO4 targets p53-senescent cell interaction pathways:

• p53 Decoupling: Drives apoptosis of senescent cells
• Reduced SASP Secretion: Lowers inflammatory aging byproducts
• Improved Tissue Renewal: Healthy cells replace dysfunctional ones
• Enhanced Mitochondrial Resilience: Supports cellular energy stability
• Organ-System Aging Benefits: Especially muscle, skin, and cognition

The result: healthier cellular populations and slowed biological aging.

Clinical Dosing Guide for Providers

For licensed medical professionals only.

Suggested Dosage

• Typical Protocol: 5–10mg daily for 3–5 consecutive days
• Cycle Frequency: Monthly or quarterly based on longevity strategy
• Provider discretion required for senolytic cycle management

Administration Notes

• Route: Subcutaneous injection
• Common Clinical Stacks:
• MOTS-c — metabolic and mitochondrial synergy
• Epithalon — circadian + telomere repair support
• NAD+ therapy — cellular rejuvenation complement

Reconstitution & Storage

• Reconstitute with bacteriostatic water
• Keep refrigerated after mixing
• Shelf life ≈ 30 days after reconstitution

Ideal Candidate Profile

Potentially Good Candidates

• Adults pursuing aggressive anti-aging interventions
• Individuals suffering from chronic inflammation or fatigue
• Patients recovering from stress, injury, or muscle loss
• High-performance individuals optimizing longevity

Use With Caution

• Active cancer — requires oncology clearance
• Immunocompromised patients — provider monitoring required

Potential Side Effects

Senolytic activity may cause temporary responses:

• Mild fatigue during cellular turnover
• Injection-site irritation
• Rare headaches or flu-like immune activation

Benefits typically increase after the adjustment period.

Frequently Asked Questions

1. What does FOXO4 (10mg) help with?
Selective removal of aging senescent cells, boosting regeneration.

2. How quickly does it work?
Cellular improvements progress over weeks to months.

3. Does it increase longevity?
Early research suggests strong potential — human outcome timelines vary.

4. Does it affect normal cells?
No — targeted to senescent “zombie” cells.

5. How long is a treatment cycle?
Commonly 3–5 days monthly or quarterly.

6. Will I feel tired during use?
Temporary fatigue is possible during senescent-cell clearance.

7. Can it improve cognitive health?
May support brain aging by reducing cellular toxicity.

8. Can it be combined with other longevity peptides?
Yes — strong synergy with Epithalon, MOTS-c, and NAD+ support.

9. Is it hormone-related?
No — works through cellular apoptosis pathways.

10. How is it stored?
Refrigerated post-reconstitution.

FOXO4 vs Similar Peptides

• vs Epithalon:
  Epithalon protects DNA + telomeres; FOXO4 clears dysfunctional cells.
• vs MOTS-c:
  MOTS-c enhances energy metabolism — great senolytic combo.
• vs TA1:
  TA1 regulates immunity; FOXO4 improves aging-cell cleanup.

Research & Evidence Overview

Preclinical and early clinical research supports:

• Selective senescent cell apoptosis
• Improved muscle and tissue recovery
• Reduced systemic inflammation
• Enhanced cellular and organ function

A leading peptide candidate in longevity and regenerative medicine.

Product & Purity Assurance

99% purity

• COA and endotoxin tested
• cGMP-grade manufacturing
• Provider-exclusive dispensing

Legal & Medical Disclaimer

For licensed medical professionals only. Not intended to diagnose, treat, or cure any condition.